{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:49:01Z","timestamp":1791676141946,"version":"4.3.4"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07280-x","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:19:32Z","timestamp":1789352372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Presenting a multi-marker response-adapted framework for venetoclax duration in acute myeloid leukemia"],"prefix":"10.1007","volume":"105","author":[{"given":"Nabiha","family":"Adnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"7280_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12938-025-01403-7","volume":"24","author":"X Han","year":"2025","unstructured":"Han X, Yun Z, Liu Z, Si Y, Tian S, Zhang Y, Qi Y, Xue C, Cui M, Wen X, Zhang Y, Hou L (2025) Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: Findings from the Global Burden of Disease Study 2021. Biomed Eng Online 24:72. https:\/\/doi.org\/10.1186\/s12938-025-01403-7","journal-title":"Biomed Eng Online"},{"issue":"11","key":"7280_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/13696998.2018.1513847","volume":"21","author":"M Hagiwara","year":"2018","unstructured":"Hagiwara M, Sharma A, Chung KC, Delea TE (2018) Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia. J Med Econ 21(11):1119\u20131130. https:\/\/doi.org\/10.1080\/13696998.2018.1513847","journal-title":"J Med Econ"},{"key":"7280_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-07246-z","author":"M Chen","year":"2026","unstructured":"Chen M, Chen Y, Wang S (2026) Early bone marrow-guided venetoclax management in frontline unfit acute myeloid leukemia: a two-stage real-world study. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-026-07246-z","journal-title":"Ann Hematol"},{"issue":"26","key":"7280_CR4","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, B\u00e9n\u00e9 MC, B\u00fccklein V, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK, Cloos J (2021) 2021 Update on MRD in acute myeloid leukemia: A consensus document from the European LeukemiaNet MRD Working Party. Blood 138(26):2753. https:\/\/doi.org\/10.1182\/blood.2021013626","journal-title":"Blood"},{"key":"7280_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40364-025-00869-w","volume":"13","author":"A Bancos","year":"2025","unstructured":"Bancos A, Ivancuta A, Moisoiu V (2025) Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies. Biomark Res 13:153. https:\/\/doi.org\/10.1186\/s40364-025-00869-w","journal-title":"Biomark Res"},{"issue":"1","key":"7280_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10238-025-01858-x","volume":"25","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H (2025) Integrating multi-omics approaches in acute myeloid leukemia (AML): Advancements and clinical implications. Clin Exp Med 25(1):311. https:\/\/doi.org\/10.1007\/s10238-025-01858-x","journal-title":"Clin Exp Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07280-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:07:00Z","timestamp":1791673620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07280-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":6,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7280"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07280-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"31 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"414"}}